Koers Quick-Med Technologies, Inc. Other OTC
Aandelen
QMDT
US74837Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2012 | 997K 922K | Omzet 2013 | 928K 858K | Marktkapitalisatie | 2,28 mln. 2,1 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | -1 mln. -924K | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 | 10,8 x |
Nettoschuld 2012 | 7,43 mln. 6,87 mln. | Nettoschuld 2013 | 7,86 mln. 7,27 mln. | EV/omzet 2013 | 10,9 x |
K/w-verhouding 2012 |
-1,99
x | K/w-verhouding 2013 |
-3,19
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Liesenfeld
PSD | President | 53 | 01-01-04 |
William Toreki
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-02 |
Gregory Schultz
BRD | Director/Board Member | 73 | 01-07-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Olderman
BRD | Director/Board Member | 90 | 01-07-97 |
Gregory Schultz
BRD | Director/Board Member | 73 | 01-07-00 |
Dale Bergman
BRD | Director/Board Member | 67 | 28-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+64,23% | 62,59 mld. | |
-2,31% | 41,18 mld. | |
+43,96% | 40,29 mld. | |
-8,29% | 27,9 mld. | |
+11,97% | 26,21 mld. | |
-21,16% | 19,09 mld. | |
+7,54% | 13,08 mld. | |
+27,17% | 12,05 mld. | |
+25,72% | 12,26 mld. |